Peter O’Donnell - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Peter O’Donnell's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayPeter O’Donnell
Verified
Brussels Correspondent, APM Health Europe
Brussels
Beats
business content tech content, -, and lifestyle content and local news. human interest, mental health climate and environmental justice., International
ask me and I will let you know.
Content
Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum‐containing chemotherapy: Post hoc analysis of KEYNOTE‐052 and LEAP‐011
Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum‐containing chemotherapy: Post hoc analysis of KEYNOTE‐052 and LEAP‐011
Company Info
APM Health Europe
, Ile-de-France, France
'+44 20 7324 2327
Founded: